3000+ Attendees, 450 Speakers, 12 Conference Tracks, 100+ Posters
 
MMTC15_Header  
MMTC M Header 

Cambridge Healthtech Institute’s Inaugural

Genomic Technologies for Patient Stratification

Unlocking New Markers to Ensure Successful Treatment

February 15-18, 2015 | Moscone North Convention Center | San Francisco, CA
Part of the 22nd Annual Molecular Medicine Tri-Conference

 

Genomic technologies such as PCR, NGS, and microarray are becoming essential leading up to, and during, clinical trials as more patients demand personalized treatment. Genomic Technologies for Patient Stratification will showcase novel technologies and techniques that are being used by researchers to stratify patient populations into an appropriate trial. Emphasis will be placed on identifying and generating new biomarker leads to maximize the chances of successful treatment. The importance of high-speed and accurate methods for marker detection will also be examined, and case studies using new techniques and technologies to take advantage of a patient's genotype will be  showcased. Early patient stratification is critical to enable effective and personalized drug discovery and development. This event will provide attendees with the knowledge and tools to move forward in the rapidly advancing area of personalized medicine.

Who Should Attend: VPs, Directors, Managers, CEOs, CSOs, Professors and Scientists from Pharma, Biotechs and Academia working in fields of Diagnostics, Biomarkers, R&D, Chemistry, Clinical Research, Clinical Trials, in vitro Diagnostics, Personalized Healthcare, Process Development, and Oncology.

Topics may include, but are not limited to: 

  • Genomic-based oncology clinical development
  • Identifying new biomarkers
  • Companion diagnostics tools
  • Technologies to personalize clinical trials  (dPCR, NGS, microarray)
  • Growth of accurate, high speed methods for sequencing
  • Patient recruitment using biomarker analysis tools
  • Looking beyond direct molecular targets of drugs
  • Unlocking new markers for stratification

If you would like to submit a proposal to give a presentation at this meeting, please click here 

The deadline for submission is July 18, 2014. 

All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program.  Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academia. Additionally, vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

For more details on the conference, please contact:
Samantha Lewis
Conference Director
Cambridge Healthtech Institute
T: (+1) 781-972-5461
E: slewis@healthtech.com 

For partnering and sponsorship information, please contact: 

Jon Stroup (Companies A-K)
Manager, Business Development
Cambridge Healthtech Institute
T: (+1) 781-972-5483
E: jstroup@healthtech.com 

Joseph Vacca (Companies L-Z) 
Manager, Business Development
Cambridge Healthtech Institute
T: (+1) 781.972.5431
E: jvacca@healthtech.com
 

 



Premier Sponsors:

Leica Biosystems 
 

 NanoString2   

 

Singulex 

 

Jackson Laboratory - small logo